shop
Investors
View our range of topical creams, moisturisers and soap-alternatives uniquely formulated to relieve symptoms associated with various skin conditions including psoriasis, eczema, dandruff, scabies, fungal infections, and dry or irritated skin.
May 26, 2025
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
April 24, 2024
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….